Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients

Fig. 4

Comparative kinetics of NAbs induced by natural immunity versus BNT162b2 mRNA vaccination. NAbs titer in COVID-19 patients (D10, D16, D39 from symptoms onset; SARS-CoV-2), convalescent plasma donors (D60 from symptoms onset; PLS), and in vaccinated individuals (NEG at D1; BNT162b2) at roughly matched (per group) time points

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us